Breo Ellipta

Breo Ellipta (fluticasone/vilanterol) is a prescription medication used to treat Asthma, COPD. A once-daily maintenance inhaler for asthma and COPD that combines a steroid and a long-acting bronchodilator.

An inhaled steroid lowers airway inflammation while a long-acting beta agonist relaxes the airways for 24 hours.

Commonly reported side effects of Breo Ellipta include Oral thrush, Throat irritation, Headache, Common cold symptoms, and Hoarseness. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Breo Ellipta does not carry an FDA Boxed Warning, but every prescription medicine has risks and possible interactions. Always follow your doctor's instructions and read the medication guide that comes with it.

The active ingredient in Breo Ellipta is fluticasone/vilanterol, which belongs to a class of medicines known as ICS/LABA Inhaler.

Breo Ellipta is manufactured by GSK. It was first approved in 2013.

You may be able to lower the cost of Breo Ellipta by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.